🇺🇸 FDA
Pipeline program

Palbociclib 125Mg Tab

CCR5316

Phase 2 small_molecule active

Quick answer

Palbociclib 125Mg Tab for ER+ Breast Cancer is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
ER+ Breast Cancer
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials